Constable, Ian J.,Rakoczy, P. Elizabeth,Lai, Chooi-may,Chalberg Jr., Thomas W.
申请号：
AU2018211212
公开号：
AU2018211212A1
申请日:
2018.07.31
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018211212A120180816.pdf#####ABSTRACT The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase-1 (sFlt-1) protein to the human subject.
